SEC Tracker
Get the app
DRIO · XBRL financial data

DarioHealth financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (DRIO's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025†Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cost of goods and services sold2,9083,484*3,3263,4993,5463,402*2,8702,4051,9922,427*2,3841,985
Gross profit610—2,4322,7563,877—3,8822,9643,015—3,2003,192
Research and development5,6654,196*6,6426,8105,4465,281*4,1083,7213,3282,634*2,3852,100
General and administrative4,1285,529*6,7355,0053,7285,014*3,3103,2124,5674,102*3,2262,600
Total operating expenses16,15614,347*20,28718,94715,90715,870*13,29112,16412,49911,366*10,5099,671
Operating income (loss)(15,546)(14,215)*(17,855)(16,191)(12,030)(11,668)*(9,409)(9,200)(9,484)(8,562)*(7,309)(6,479)
Interest income534*470*390339226161*289237175242*160135
Interest expense————————1,1571,097*1,1491,123
Other income (expense)————(313)2,191*204(3,790)175711*2666
Income tax expense (benefit)—year only(1,994)0*(13)155*220083*57328
Net income (loss)(15,732)(14,285)*(7,175)(13,610)(12,330)(9,632)*(9,227)(12,990)(10,466)(9,031)*(8,249)(7,924)
Earnings per share, basic‡ USD per share9.80—4.001.605.00—2.803.602.96—1.250.85
Earnings per share, diluted‡ USD per share9.80—4.001.605.00—2.803.602.96—1.250.85
Weighted average shares, basic‡ thousands of shares1,4411,445*1,7221,9922,021—2,3692,4823,138—6,5829,344
Weighted average shares, diluted‡ thousands of shares1,4411,445*1,7221,9922,021—2,3692,4823,138—6,5829,344
  • ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (August 2025); filings made before it reported them unadjusted.
  • † Share count changed about 3x in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (DRIO's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025†Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents43,87836,79734,36722,93815,54727,76427,85421,95431,90721,80314,9776,634
Short-term investments—————————4,2145,0357,327
Inventory5,4715,0624,9165,1334,7424,7534,6224,6094,8694,3164,1723,719
Prepaid and other current assets1,9342,0244,3703,6793,4282,3362,6872,8332,8122,3612,0792,604
Total current assets56,21147,33052,50939,34029,52840,52938,56232,17042,18535,06728,73422,126
Property and equipment, net9998991,4251,3341,235709646610578549511503
Right-of-use asset9789671,8131,5471,3061,0659558617467176071,029
Goodwill41,64041,64057,42757,42757,42757,42757,42757,42757,42757,42757,42757,427
Total assets106,50596,389136,964122,134109,953118,884115,600108,325117,727110,075103,28196,590
Accrued liabilities—2,227———1,940———2,402——
Current portion of long-term debt—3,9543,9545,1918,6705,45110,295—————
Total current liabilities8,10612,49317,80217,41618,84616,63519,1559,7549,2799,3239,3579,578
Long-term debt29,00024,59124,50823,44020,18723,47218,89930,49930,61730,74730,93131,064
Lease liability, non-current8048851,0531,1181,033765653612579571507777
Accumulated deficit(333,855)(349,361)(358,570)(363,474)(378,082)(390,343)(404,409)(422,971)(441,826)(452,078)(460,327)(468,251)
Total stockholders' equity68,03558,14478,03368,05558,51172,01973,69963,98674,93467,92262,38055,088
Total liabilities and equity106,50596,389136,964122,134109,953118,884115,600108,325117,727110,075103,28196,590
Common shares outstanding (cover page)‡ thousands of shares1,3611,4721,4961,5011,7052,0782,1972,2756,7687,3007,3129,799
  • ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (August 2025); filings made before it reported them unadjusted.
  • † Share count changed about 3x in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (DRIO's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025†Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(15,732)(14,285)*(7,175)(13,610)(12,330)(9,632)*(9,227)(12,990)(10,466)(9,031)*(8,249)(7,924)
Stock-based compensation—————year only——————
Net cash from operating activities(8,645)*(7,341)*(13,110)(11,363)*(7,357)*(6,732)*(6,673)(6,031)*(7,350)*(5,887)*(6,025)(6,083)*
Purchases of property and equipment281*83*5629*32*21*3144*41*26*3138*
Net cash from investing activities(281)*(83)*(8,852)(29)*(32)*(21)*(31)(44)*(41)*(4,226)*(826)(2,287)*
Repayments of long-term debt0*0*——————0*0*——
Net cash from financing activities204*0*20,2060*0*18,325*6,815124*17,393*(19)*——
  • † Share count changed about 3x in the period ending 2025-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
DarioHealth6,634not reported(6,083)*9.8M2.3 quarters 10-QJun 30, 2026
electroCore8,5019,450(3,518)*9.0M2.9 quarters 10-QJun 30, 2026
Nephros4,6976,017681*10.9M— 10-QJun 30, 2026
RenovoRx9,479909(2,867)*45.1M3.3 quarters 10-QJun 30, 2026
Femasys1,444332(3,936)*8.4M0.4 quarters 10-QJun 30, 2026
Precision Optics9,8418,774*(649)*11.0M15.2 quarters 10-KJun 30, 2026
Neuroone Medical Technologies2,0481,973(1,082)*9.1M1.9 quarters 10-QJun 30, 2026
United Health Products240(138)*262.7M0.2 quarters 10-QJun 30, 2026
Cerenome2,366411(7,132)*7.6M1.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.